Antibe Therapeutics price target lowered to C$0.50 from C$0.70 at Canaccord

Canaccord analyst Tania Gonsalves lowered the firm’s price target on Antibe Therapeutics to C$0.50 from C$0.70 and keeps a Hold rating on the shares.